Conference and Exhibition - Barcelona, Spain
Market researchers have estimated that the Nanomedicine industry was worth over $72.8billion in 2011 and is expected to grow rapidly to the level of influencing entire economies. Due to major advances in science and engineering, the relatively young field of nanotechnology has been expanding significantly. Despite the exciting advancements in this discipline, which involves miniscule manufactured products 1 – 100nm in size, the field of nanomedicine has yet to be exploited to its full potential. A large part of the nanomedicine industry is within the use of nanoparticles for the treatment of cancerous tumors. However, many nanoparticles show signs of toxicity in cells and this can be caused by the inherent properties, size and surface charge of the particles. This leaves the door open for engineered solutions to enable nanomedicine to continue progressing at its historic rate.
This conference will aim to provide a multidisciplinary approach to tackle the fundamental challenges in this speciality, innovative strategies for testing exposure, and techniques for improving the reliability and accuracy of results.
(Courtesy of Hotel Rey Juan Carlos I, via http://selectbiosciences.com/)
Thu, Apr 11, 2013 - Fri, Apr 12, 2013
Hotel Rey Juan Carlos I
Av. Diagonal 661 - 671, 08028, Barcelona, Spain
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
